{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:11:20Z","timestamp":1790831480768,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Suzhou Biomedical Engineering Tianjiin Engineering Technology Research Institute Chinese Academy of Sciences"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.cca.2019.07.026","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T20:30:20Z","timestamp":1564086620000},"page":"21-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["A high-throughput LC-MS\/MS method for the quantification of four immunosu- ppressants drugs in whole blood"],"prefix":"10.1016","volume":"498","author":[{"given":"Zi-Shan","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Nian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Mei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Pei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Yan-Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Wei-Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Yan-Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2019.07.026_bb0005","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/FTD.0b013e318192304c","article-title":"Robust, high-throughput LC-MS\/MS method for therapeutic Drug Monitoring of cyclosporin A, tacrolimus, everolimus and sirolimus in whole blood","volume":"31","author":"Koster","year":"2009","journal-title":"Ther. Drug Monit."},{"issue":"6","key":"10.1016\/j.cca.2019.07.026_bb0010","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s40267-017-0403-0","article-title":"A review on therapeutic drug monitoring of the mTOR class of immunosuppressants: everolimus and sirolimus","volume":"33","author":"Jacob","year":"2017","journal-title":"Drugs & Ther. Perspectiv."},{"issue":"5","key":"10.1016\/j.cca.2019.07.026_bb0015","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ejhpharm-2012-000258","article-title":"Equivalence and interchangeability of narrow therapeutic index drugs in organ transplantation","volume":"20","author":"Johnston","year":"2013","journal-title":"Eur. J. of Hospital Pharm. Sci. and Pract."},{"issue":"1","key":"10.1016\/j.cca.2019.07.026_bb0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/FTD.0000000000000364","article-title":"A systematic literature review approach to estimate the therapeutic index of selected immunosuppressant drugs after renal transplantation","volume":"39","author":"Ericson","year":"2017","journal-title":"Ther. Drug Monit."},{"issue":"1","key":"10.1016\/j.cca.2019.07.026_bb0025","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1016\/j.jhep.2015.02.042","article-title":"From immunosuppression to tolerance","volume":"62","author":"Adams","year":"2015","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.cca.2019.07.026_bb0030","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.nano.2014.12.003","article-title":"Therapeutic applications of nanomedicine in autoimmune diseases: from immunosuppression to tolerance induction","volume":"11","author":"Gharagozloo","year":"2015","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.cca.2019.07.026_bb0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/dta.2290","article-title":"Recent advances in analytical methods for the therapeutic drug monitoring of immunosuppressive drugs","volume":"10","author":"Zhang","year":"2018","journal-title":"Drug testing and analysis"},{"issue":"4","key":"10.1016\/j.cca.2019.07.026_bb0040","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/BF01973261","article-title":"Biological effects of cyclosporin A-a new anti-lymphocytic agent","volume":"6","author":"Borel","year":"1976","journal-title":"Agents Actions"},{"key":"10.1016\/j.cca.2019.07.026_bb0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1139\/y77-007","article-title":"Inhibition of the immune response by rapamycin, new antifungal antibiotic","volume":"55","author":"Martel","year":"1977","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.cca.2019.07.026_bb0050","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.7164\/antibiotics.40.1256","article-title":"FK-506, a novel immunosuppressant isolated from a Streptomyces. II","volume":"40","author":"Kino","year":"1987","journal-title":"J. Antibiot."},{"key":"10.1016\/j.cca.2019.07.026_bb0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/FTD.0b013e3181c49a00","article-title":"Ultra fast liquid chromatography\u2013tandem mass spectrometry routine method for simultaneous determination of Cyclosporin a, tacrolimus, Sirolimus, and Everolimus in whole blood using deuterated internal standards for Cyclosporin a and Everolimus","volume":"32","author":"Andreas Meinitzer","year":"2010","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.cca.2019.07.026_bb0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.trac.2015.11.026","article-title":"LC-MS\/MS for therapeutic drug monitoring of anti-infective drugs","volume":"84","author":"Veringa","year":"2016","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.cca.2019.07.026_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2015.12.027","article-title":"Therapeutic drug monitoring of immunosuppressants by liquid chromatography-mass spectrometry","volume":"454","author":"McShane","year":"2016","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"key":"10.1016\/j.cca.2019.07.026_bb0070","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.trac.2015.11.016","article-title":"Recent advances in therapeutic drug monitoring of immunosuppressive drugs","volume":"79","author":"Freudenberger","year":"2016","journal-title":"TrAC Trends Anal. Chem."},{"issue":"23\u201324","key":"10.1016\/j.cca.2019.07.026_bb0075","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s10337-015-2981-0","article-title":"Simultaneous measurement of cyclosporine a, Everolimus, Sirolimus and tacrolimus concentrations in human blood by UPLC\u2013MS\/MS","volume":"78","author":"Rigo-Bonnin","year":"2015","journal-title":"Chromatographia"},{"issue":"7","key":"10.1016\/j.cca.2019.07.026_bb0080","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00216-007-1320-1","article-title":"Current role of LC-MS in therapeutic drug monitoring","volume":"388","author":"Saint-Marcoux","year":"2007","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.cca.2019.07.026_bb0085","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.cca.2014.01.027","article-title":"Clinical evaluation of the QMS(R) tacrolimus immunoassay","volume":"431","author":"Leung","year":"2014","journal-title":"Clinica Chimica Acta; Int. J. Clin. Chem."},{"key":"10.1016\/j.cca.2019.07.026_bb0090","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jchromb.2018.04.028","article-title":"Simultaneous determination of cyclosporine and tacrolimus in human whole blood by ultra-high performance liquid chromatography tandem mass spectrometry and comparison with a chemiluminescence microparticle immunoassay","volume":"1087-1088","author":"Mei","year":"2018","journal-title":"J. Chromatogr. B"},{"issue":"4","key":"10.1016\/j.cca.2019.07.026_bb0095","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nprot.2009.25","article-title":"A rapid HPLC-MS\/MS method for the simultaneous quantification of cyclosporine a, tacrolimus, sirolimus and everolimus in human blood samples","volume":"4","author":"Seger","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.cca.2019.07.026_bb0100","series-title":"Liquid Chromatography-Mass Spectrometry Methods; Approved Guideline. CLSI Document C62-A","author":"CLSI","year":"2014"},{"key":"10.1016\/j.cca.2019.07.026_bb0105","series-title":"Metrological Traceability and its Implementation; a Report. CLSI Document EP32-R","author":"CLSI","year":"2006"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811931976X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811931976X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:48:41Z","timestamp":1757861321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000989811931976X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":21,"alternative-id":["S000989811931976X"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2019.07.026","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A high-throughput LC-MS\/MS method for the quantification of four immunosu- ppressants drugs in whole blood","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2019.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}